Notice/News
Notice/News
The external news articles in this bulletin have been collected and published solely for the purpose of providing information and may differ from our official position. We make no guarantee of the accuracy, timeliness, or completeness of the content of the article and are not liable for any direct or indirect damage that may occur.
Number
Title
Date
1
[The Bio] ToolGen CEO Yoo Jong-sang Says Priority Proceedings with Broad Are Gaining Momentum, Vows to Secure Gene-Editing IP Rights
2026.07.28
2
[Notice] A Message to Our Shareholders
2026.07.25
3
[Notice] Announcement of Record Date for New Share Allocation and Suspension of Shareholder Register Transfers
2026.07.22
4
[Notice] Announcement of New Share Issuance
2026.07.22
5
[Notice] Frequently Asked Questions (FAQ)
2026.07.14
6
[Notice] Announcement of New Share Issuance
2026.06.22
7
[Notice] Announcement of Record Date for New Share Allocation and Suspension of Shareholder Register Transfers
2026.06.22
8
[Press Release] Gene Editing Council Welcomes European Parliament’s Final Approval of NGT Legislation
2026.06.18
9
[Press Release] ToolGen Opens Global Gene-Edited Seed LMO Field at Osong Innovation Center, Targets SAF and Industrial Crop Markets
2026.06.11
10
[Notice] A Message to Our Shareholders
2026.06.08
11
[The Bio] ToolGen to Leverage Financial Strength in Global Gene-Editing IP Battle
2026.06.01
12
[Notice] Status of CRISPR RNP Patent Infringement Lawsuits in Europe and the U.S.
2026.06.01
13
[Notice] Update on Recent European Patent Matters
2026.05.29
14
[Press Release] ToolGen to Raise KRW 70 Billion Through Rights Offering to End Global Patent Battles and Secure Market Dominance
2026.05.15
15
[Notice] Announcement of New Share Issuance
2026.05.15